{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T22:40:21Z","timestamp":1788993621028,"version":"build-2803163510"},"reference-count":58,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82002564"],"award-info":[{"award-number":["82002564"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82203548"],"award-info":[{"award-number":["82203548"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82272873"],"award-info":[{"award-number":["82272873"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100016305","name":"Zhengzhou University First Affiliated Hospital","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100016305","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2023,8]]},"DOI":"10.1016\/j.intimp.2023.110457","type":"journal-article","created":{"date-parts":[[2023,6,16]],"date-time":"2023-06-16T18:31:36Z","timestamp":1686940296000},"page":"110457","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["IL8 derived from macrophages inhibits CD8+ T-cell function by downregulating TIM3 expression through IL8-CXCR2 axis in patients with advanced colorectal cancer"],"prefix":"10.1016","volume":"121","author":[{"given":"Chenhui","family":"Zhao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhen","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhen","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yujie","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinbo","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingyang","family":"Lei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dong","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yachang","family":"Huo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shasha","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ling","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9861-4681","authenticated-orcid":false,"given":"Yi","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.intimp.2023.110457_b0005","first-page":"7","article-title":"Cancer statistics, 2022","volume":"72","author":"Siegel","year":"2022","journal-title":"CA Cancer J. Clin."},{"issue":"7","key":"10.1016\/j.intimp.2023.110457_b0010","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1001\/jama.2021.0106","article-title":"Diagnosis and treatment of metastatic colorectal cancer: a review","volume":"325","author":"Biller","year":"2021","journal-title":"J. Am. Med. Assoc."},{"issue":"12","key":"10.1016\/j.intimp.2023.110457_b0015","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1093\/bjs\/znab342","article-title":"Neoadjuvant immunotherapy in primary and metastatic colorectal cancer","volume":"108","author":"Kanani","year":"2021","journal-title":"Br. J. Surg."},{"key":"10.1016\/j.intimp.2023.110457_b0020","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.ctrv.2017.01.008","article-title":"The expanding role of immunotherapy","volume":"54","author":"Martin-Liberal","year":"2017","journal-title":"Cancer Treat. Rev."},{"issue":"1","key":"10.1016\/j.intimp.2023.110457_b0025","doi-asserted-by":"crossref","DOI":"10.1172\/JCI140281","article-title":"Protein tyrosine phosphatase nonreceptor type 2 controls colorectal cancer development","volume":"131","author":"Katkeviciute","year":"2021","journal-title":"J. Clin. Invest."},{"issue":"1","key":"10.1016\/j.intimp.2023.110457_b0030","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/s12943-021-01322-w","article-title":"Cross-talk of four types of RNA modification writers defines tumor microenvironment and pharmacogenomic landscape in colorectal cancer","volume":"20","author":"Chen","year":"2021","journal-title":"Mol. Cancer"},{"issue":"1","key":"10.1016\/j.intimp.2023.110457_b0035","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1186\/s13045-021-01103-4","article-title":"Spatial architecture of the immune microenvironment orchestrates tumor immunity and therapeutic response","volume":"14","author":"Fu","year":"2021","journal-title":"J. Hematol. Oncol."},{"issue":"2","key":"10.1016\/j.intimp.2023.110457_b0040","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1038\/s41416-020-01048-4","article-title":"Cytotoxic CD8(+) T cells in cancer and cancer immunotherapy","volume":"124","author":"Raskov","year":"2021","journal-title":"Br. J. Cancer"},{"issue":"1","key":"10.1016\/j.intimp.2023.110457_b0045","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2020-000911","article-title":"Tim-3 finds its place in the cancer immunotherapy landscape","volume":"8","author":"Acharya","year":"2020","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.intimp.2023.110457_b0050","doi-asserted-by":"crossref","first-page":"6072","DOI":"10.1038\/ncomms7072","article-title":"An IL-27\/NFIL3 signalling axis drives Tim-3 and IL-10 expression and T-cell dysfunction","volume":"6","author":"Zhu","year":"2015","journal-title":"Nat. Commun."},{"key":"10.1016\/j.intimp.2023.110457_b0055","doi-asserted-by":"crossref","DOI":"10.1155\/2020\/5294043","article-title":"Prognostic Impact of PD-1 and Tim-3 Expression in Tumor Tissue in Stage I-III Colorectal Cancer","volume":"2020","author":"Kuai","year":"2020","journal-title":"Biomed Res. Int."},{"issue":"1","key":"10.1016\/j.intimp.2023.110457_b0060","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2021.1954761","article-title":"Expression of the immune checkpoint receptors PD-1, LAG3, and TIM3 in the immune context of stage II and III gastric cancer by using single and chromogenic multiplex immunohistochemistry","volume":"10","author":"Park","year":"2021","journal-title":"Oncoimmunology"},{"issue":"1","key":"10.1016\/j.intimp.2023.110457_b0065","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2016.1261241","article-title":"Prognostic and predictive aspects of the tumor immune microenvironment and immune checkpoints in malignant pleural mesothelioma","volume":"6","author":"Marcq","year":"2017","journal-title":"Oncoimmunology"},{"issue":"1","key":"10.1016\/j.intimp.2023.110457_b0070","doi-asserted-by":"crossref","DOI":"10.1186\/s13148-019-0752-8","article-title":"Molecular and immune correlates of TIM-3 (HAVCR2) and galectin 9 (LGALS9) mRNA expression and DNA methylation in melanoma","volume":"11","author":"Holderried","year":"2019","journal-title":"Clin. Epigenetics"},{"issue":"1","key":"10.1016\/j.intimp.2023.110457_b0075","doi-asserted-by":"crossref","first-page":"8869","DOI":"10.1038\/s41598-017-09484-8","article-title":"Low TIM3 expression indicates poor prognosis of metastatic prostate cancer and acts as an independent predictor of castration resistant status","volume":"7","author":"Wu","year":"2017","journal-title":"Sci. Rep."},{"issue":"10","key":"10.1016\/j.intimp.2023.110457_b0080","doi-asserted-by":"crossref","first-page":"2565","DOI":"10.1158\/1078-0432.CCR-15-1732","article-title":"Systemic Immune Activity Predicts Overall Survival in Treatment-Naive Patients with Metastatic Pancreatic Cancer","volume":"22","author":"Farren","year":"2016","journal-title":"Clin Cancer Res"},{"issue":"3","key":"10.1016\/j.intimp.2023.110457_b0085","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1038\/ni.3384","article-title":"Inflammatory networks underlying colorectal cancer","volume":"17","author":"Lasry","year":"2016","journal-title":"Nat. Immunol."},{"issue":"6","key":"10.1016\/j.intimp.2023.110457_b0090","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1158\/1055-9965.EPI-20-1752","article-title":"Levels of inflammation markers are associated with the risk of recurrence and all-cause mortality in patients with colorectal cancer","volume":"30","author":"Wesselink","year":"2021","journal-title":"Cancer Epidemiol. Biomark. Prev."},{"issue":"5","key":"10.1016\/j.intimp.2023.110457_b0095","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1038\/s41591-020-0873-9","article-title":"IL-8 and cancer prognosis on immunotherapy","volume":"26","author":"Bakouny","year":"2020","journal-title":"Nat. Med."},{"key":"10.1016\/j.intimp.2023.110457_b0100","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.3389\/fonc.2019.01223","article-title":"IL-6 and IL-8 are linked with myeloid-derived suppressor cell accumulation and correlate with poor clinical outcomes in melanoma patients","volume":"9","author":"Tobin","year":"2019","journal-title":"Front. Oncol."},{"issue":"7","key":"10.1016\/j.intimp.2023.110457_b0105","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0041839","article-title":"Progressive increase of matrix metalloprotease-9 and interleukin-8 serum levels during carcinogenic process in human colorectal tract","volume":"7","author":"Biasi","year":"2012","journal-title":"PLoS One"},{"issue":"5","key":"10.1016\/j.intimp.2023.110457_b0110","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1038\/s41591-020-0856-x","article-title":"Elevated serum interleukin-8 is associated with enhanced intratumor neutrophils and reduced clinical benefit of immune-checkpoint inhibitors","volume":"26","author":"Schalper","year":"2020","journal-title":"Nat. Med."},{"issue":"8","key":"10.1016\/j.intimp.2023.110457_b0115","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1038\/s43018-021-00227-3","article-title":"Castration-mediated IL-8 promotes myeloid infiltration and prostate cancer progression","volume":"2","author":"Lopez-Bujanda","year":"2021","journal-title":"Nat Cancer"},{"issue":"7","key":"10.1016\/j.intimp.2023.110457_b0120","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1038\/s41419-018-0803-7","article-title":"CD45(+)CD33(low)CD11b(dim) myeloid-derived suppressor cells suppress CD8(+) T cell activity via the IL-6\/IL-8-arginase I axis in human gastric cancer","volume":"9","author":"Mao","year":"2018","journal-title":"Cell Death Dis."},{"issue":"1","key":"10.1016\/j.intimp.2023.110457_b0125","first-page":"1059","article-title":"Downregulated Tim-3 expression is responsible for the incidence and development of colorectal cancer","volume":"16","author":"Zhang","year":"2018","journal-title":"Oncol. Lett."},{"issue":"6","key":"10.1016\/j.intimp.2023.110457_b0130","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1158\/2326-6066.CIR-18-0713","article-title":"Function of Human Tumor-Infiltrating Lymphocytes in Early-Stage Non-Small Cell Lung Cancer","volume":"7","author":"O'Brien","year":"2019","journal-title":"Cancer Immunol. Res."},{"issue":"2","key":"10.1016\/j.intimp.2023.110457_b0135","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/j.nano.2016.07.011","article-title":"Physicochemical characterization of ferumoxytol, heparin and protamine nanocomplexes for improved magnetic labeling of stem cells","volume":"13","author":"Bryant","year":"2017","journal-title":"Nanomedicine"},{"issue":"1","key":"10.1016\/j.intimp.2023.110457_b0140","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1186\/s13045-020-00897-z","article-title":"Th17 cells inhibit CD8(+) T cell migration by systematically downregulating CXCR3 expression via IL-17A\/STAT3 in advanced-stage colorectal cancer patients","volume":"13","author":"Wang","year":"2020","journal-title":"J. Hematol. Oncol."},{"issue":"4","key":"10.1016\/j.intimp.2023.110457_b0145","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1038\/s41556-019-0299-0","article-title":"Extracellular vesicle-packaged HIF-1alpha-stabilizing lncRNA from tumour-associated macrophages regulates aerobic glycolysis of breast cancer cells","volume":"21","author":"Chen","year":"2019","journal-title":"Nat. Cell Biol."},{"issue":"6","key":"10.1016\/j.intimp.2023.110457_b0150","doi-asserted-by":"crossref","first-page":"1678","DOI":"10.1080\/08820139.2022.2027439","article-title":"PCSK9 suppresses M2-Like tumor-associated macrophage polarization by regulating the secretion of OX40L from hepatocellular carcinoma cells","volume":"51","author":"Hu","year":"2022","journal-title":"Immunol. Invest."},{"issue":"8","key":"10.1016\/j.intimp.2023.110457_b0155","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1016\/j.molp.2020.06.009","article-title":"TBtools: an integrative toolkit developed for interactive analyses of big biological data","volume":"13","author":"Chen","year":"2020","journal-title":"Mol. Plant"},{"issue":"11","key":"10.1016\/j.intimp.2023.110457_b0160","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1038\/s41568-020-0285-7","article-title":"The immune contexture and Immunoscore in cancer prognosis and therapeutic efficacy","volume":"20","author":"Bruni","year":"2020","journal-title":"Nat. Rev. Cancer"},{"issue":"2","key":"10.1016\/j.intimp.2023.110457_b0165","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1158\/1078-0432.CCR-18-1851","article-title":"The immunoscore: colon cancer and beyond","volume":"26","author":"Angell","year":"2020","journal-title":"Clin. Cancer Res."},{"issue":"2","key":"10.1016\/j.intimp.2023.110457_b0170","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1002\/cjp2.193","article-title":"Relationship between immune checkpoint proteins, tumour microenvironment characteristics, and prognosis in primary operable colorectal cancer","volume":"7","author":"Al-Badran","year":"2021","journal-title":"J. Pathol. Clin. Res."},{"issue":"9","key":"10.1016\/j.intimp.2023.110457_b0175","doi-asserted-by":"crossref","first-page":"2778","DOI":"10.1016\/j.clnu.2019.12.005","article-title":"Plasma inflammatory biomarkers and modifiable lifestyle factors associated with colorectal cancer risk","volume":"39","author":"Kim","year":"2020","journal-title":"Clin. Nutr."},{"issue":"11","key":"10.1016\/j.intimp.2023.110457_b0180","doi-asserted-by":"crossref","DOI":"10.3390\/jcm10112391","article-title":"Circulating biomarkers of colorectal cancer (CRC)-their utility in diagnosis and prognosis","volume":"10","author":"Lukaszewicz-Zajac","year":"2021","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.intimp.2023.110457_b0185","article-title":"CXCL8 associated dendritic cell activation marker expression and recruitment as indicators of favorable outcomes in colorectal cancer","volume":"12","author":"Li","year":"2021","journal-title":"Front. Immunol."},{"issue":"16","key":"10.1016\/j.intimp.2023.110457_b0190","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22168470","article-title":"Tumor-associated macrophages (TAMs) in colorectal cancer (CRC): from mechanism to therapy and prognosis","volume":"22","author":"Wang","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"9","key":"10.1016\/j.intimp.2023.110457_b0195","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1038\/s41423-022-00903-z","article-title":"Tumor-associated macrophage (TAM)-derived CCL22 induces FAK addiction in esophageal squamous cell carcinoma (ESCC)","volume":"19","author":"Chen","year":"2022","journal-title":"Cell. Mol. Immunol."},{"key":"10.1016\/j.intimp.2023.110457_b0200","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.canlet.2019.03.040","article-title":"Macrophage-derived CCL22 promotes an immunosuppressive tumor microenvironment via IL-8 in malignant pleural effusion","volume":"452","author":"Wang","year":"2019","journal-title":"Cancer Lett."},{"key":"10.1016\/j.intimp.2023.110457_b0205","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2021.107933","article-title":"TIM-3: an update on immunotherapy","volume":"99","author":"Zhao","year":"2021","journal-title":"Int. Immunopharmacol."},{"issue":"1","key":"10.1016\/j.intimp.2023.110457_b0210","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1038\/s41416-021-01607-3","article-title":"TIM3(+) cells in gastric cancer: clinical correlates and association with immune context","volume":"126","author":"Chen","year":"2022","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.intimp.2023.110457_b0215","doi-asserted-by":"crossref","first-page":"15659","DOI":"10.1038\/srep15659","article-title":"Apoptosis of tumor infiltrating effector TIM-3+CD8+ T cells in colon cancer","volume":"5","author":"Kang","year":"2015","journal-title":"Sci. Rep."},{"issue":"11","key":"10.1016\/j.intimp.2023.110457_b0220","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1002984","article-title":"Tim-3-expressing CD4+ and CD8+ T cells in human tuberculosis (TB) exhibit polarized effector memory phenotypes and stronger anti-TB effector functions","volume":"8","author":"Qiu","year":"2012","journal-title":"PLoS Pathog."},{"issue":"13","key":"10.1016\/j.intimp.2023.110457_b0225","doi-asserted-by":"crossref","DOI":"10.3390\/cancers14133194","article-title":"Circulating and tumor-infiltrating immune checkpoint-expressing CD8(+) Treg\/T cell subsets and their associations with disease-free survival in colorectal cancer patients","volume":"14","author":"Alsalman","year":"2022","journal-title":"Cancers (Basel)"},{"issue":"1","key":"10.1016\/j.intimp.2023.110457_b0230","article-title":"Transcriptomic profiling of tumor-infiltrating CD4(+)TIM-3(+) T cells reveals their suppressive, exhausted, and metastatic characteristics in colorectal cancer patients","volume":"8","author":"Sasidharan Nair","year":"2020","journal-title":"Vaccines (Basel)"},{"issue":"1","key":"10.1016\/j.intimp.2023.110457_b0235","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1186\/s40425-019-0785-8","article-title":"Tumor microenvironment dictates regulatory T cell phenotype: Upregulated immune checkpoints reinforce suppressive function","volume":"7","author":"Kim","year":"2019","journal-title":"J. Immunother. Cancer"},{"issue":"10","key":"10.1016\/j.intimp.2023.110457_b0240","doi-asserted-by":"crossref","first-page":"1989","DOI":"10.1007\/s00262-020-02593-w","article-title":"Expression of immune checkpoints and T cell exhaustion markers in early and advanced stages of colorectal cancer","volume":"69","author":"Saleh","year":"2020","journal-title":"Cancer Immunol. Immunother."},{"key":"10.1016\/j.intimp.2023.110457_b0245","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.clinbiochem.2021.06.007","article-title":"Genetic signature of CTLA-4, BTLA, TIM-3 and LAG-3 molecular expression in colorectal cancer patients: Implications in diagnosis and survival outcomes","volume":"96","author":"Kamal","year":"2021","journal-title":"Clin. Biochem."},{"issue":"12","key":"10.1016\/j.intimp.2023.110457_b0250","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1038\/s41575-019-0189-8","article-title":"Global burden of colorectal cancer: emerging trends, risk factors and prevention strategies","volume":"16","author":"Keum","year":"2019","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"issue":"10","key":"10.1016\/j.intimp.2023.110457_b0255","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1038\/s41577-021-00534-x","article-title":"The inflammatory pathogenesis of colorectal cancer","volume":"21","author":"Schmitt","year":"2021","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.intimp.2023.110457_b0260","doi-asserted-by":"crossref","DOI":"10.1016\/j.cyto.2020.155205","article-title":"An overview of the role of interleukin-8 in colorectal cancer","volume":"135","author":"Najdaghi","year":"2020","journal-title":"Cytokine"},{"issue":"1","key":"10.1016\/j.intimp.2023.110457_b0265","doi-asserted-by":"crossref","first-page":"4287","DOI":"10.1038\/s41598-020-80785-1","article-title":"A prognostic model for colorectal cancer based on CEA and a 48-multiplex serum biomarker panel","volume":"11","author":"Bjorkman","year":"2021","journal-title":"Sci. Rep."},{"issue":"7710","key":"10.1016\/j.intimp.2023.110457_b0270","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1038\/s41586-018-0206-z","article-title":"Induction and transcriptional regulation of the co-inhibitory gene module in T cells","volume":"558","author":"Chihara","year":"2018","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.intimp.2023.110457_b0275","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1186\/s13045-019-0804-8","article-title":"Tumor-intrinsic signaling pathways: key roles in the regulation of the immunosuppressive tumor microenvironment","volume":"12","author":"Yang","year":"2019","journal-title":"J. Hematol. Oncol."},{"issue":"1","key":"10.1016\/j.intimp.2023.110457_b0280","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1038\/s41392-021-00484-9","article-title":"Targeting tumor-associated macrophages to synergize tumor immunotherapy","volume":"6","author":"Xiang","year":"2021","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.intimp.2023.110457_b0285","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1186\/1471-2407-14-330","article-title":"Tumor-associated macrophage-derived IL-6 and IL-8 enhance invasive activity of LoVo cells induced by PRL-3 in a KCNN4 channel-dependent manner","volume":"14","author":"Xu","year":"2014","journal-title":"BMC Cancer"},{"issue":"1","key":"10.1016\/j.intimp.2023.110457_b0290","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.imbio.2012.01.019","article-title":"RNAi screen in apoptotic cancer cell-stimulated human macrophages reveals co-regulation of IL-6\/IL-10 expression","volume":"218","author":"Ley","year":"2013","journal-title":"Immunobiology"}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576923007804?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576923007804?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T17:57:46Z","timestamp":1761587866000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567576923007804"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8]]},"references-count":58,"alternative-id":["S1567576923007804"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2023.110457","relation":{},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2023,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"IL8 derived from macrophages inhibits CD8+ T-cell function by downregulating TIM3 expression through IL8-CXCR2 axis in patients with advanced colorectal cancer","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2023.110457","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"110457"}}